logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Pediatric R/R AML: venetoclax plus chemo is viewed as a step forward

Findings warrant testing the regimen for newly diagnosed high-risk AML.